Small molecule PI 3-kinase inhibitors and methods of their use

Details Small molecule PI 3-kinase inhibitors and methods of their use Small molecule PI 3-kinase inhibitors and methods of their use

2003-11-21

2008-09-09

Balasubram, Venkataraman (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

C514S275000, C514S272000, C514S231500, C514S269000, C544S321000, C544S330000, C544S331000, C544S114000

Reexamination Certificate

active

07423148

ABSTRACT:
Compounds having formula I are provided where the variables have the values described herein.Pharmaceutical formulations include the compounds or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier and combinations with other agents. A method of treating a patient comprises administering a pharmaceutical formulation according to the invention to a patient in need thereof.

REFERENCES:
patent: 3975384 (1976-08-01), Narr et al.
patent: 4929726 (1990-05-01), Strekowski et al.
patent: 5786355 (1998-07-01), Konno et al.
patent: 5976758 (1999-11-01), Fukui et al.
patent: 5990105 (1999-11-01), Bös et al.
patent: 6251900 (2001-06-01), Kawashima et al.
patent: 6288228 (2001-09-01), Henkin et al.
patent: 6495558 (2002-12-01), Armistead et al.
patent: 6599926 (2003-07-01), Pinto et al.
patent: 6603000 (2003-08-01), Yee et al.
patent: 6743788 (2004-06-01), Cirillo et al.
patent: 6846928 (2005-01-01), Bebbington et al.
patent: 2004/0002496 (2004-01-01), Bebbington et al.
patent: 2004/0009974 (2004-01-01), Bebbington et al.
patent: 2004/0009981 (2004-01-01), Bebbington et al.
patent: 2005/0014753 (2005-01-01), Ding et al.
patent: 2341925 (1975-03-01), None
patent: 0 459 830 (1991-12-01), None
patent: 0459 830 (1991-12-01), None
patent: 1 277 738 (2003-01-01), None
patent: 1 277 741 (2003-01-01), None
patent: WO 00/43373 (2000-07-01), None
patent: WO 01/72745 (2001-10-01), None
patent: WO 01/83456 (2001-11-01), None
patent: WO 02/22608 (2002-03-01), None
patent: WO 02/36586 (2002-05-01), None
patent: WO 02/062789 (2002-08-01), None
patent: WO 02/102313 (2002-12-01), None
patent: WO 03/030909 (2003-04-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Wolft Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutices, 3ed.”, Marcel Dekker, New York. 1996, pp. 451 and 596.
Li et al., Breast Cancer Res. Treat. 1-5, 2005.
Crowder et al., Breast Cancer Res., 7(5): 212-214, 2005.
Nahta et al., Curr. Med. Chem. Anti-Canc. Agents., 3(3) 201-216, 2003.
Sharma et al., Indian Journal of Chemistry, Section B: Organic Chemistry including Medicinal Chemistry 38B(8), 966-968, 1999. CA 132:207818, 2000.
Kothari et al., Indian Journal of Heterocyclic Chemistry, 8(4), 285-288, 1999. CA 131: 257250, 1999.
Mokrosz et al., Archiv der Pharmazie, 328(9), 659-666, 1995. CA 124: 223, 1995.
Sukhwal et al., Indian Journal of Heterocyclic Chemistry,4(1), 67-68, 1994. CA 122: 105796, 1995.
Mikhaleva et al., Khimiya Geterotsiklicheskikh Soedinenii 6, 821-826, 1979. CA 91: 107951, 1979.
Tani et al., JP 49021148, CA 82: 140173, 1975.
Mamaev et al., Reaktsionnaya Sposobnost Organicheskikh Soedinenii 5(3), 824-837, 1968. CA 70: 76976, 1969.
Falco et al., British Journal of Pharmacology and Chemotherapy, 6, 185-200, 1951. CA 46: 27482, 1952.
Andrisano, Bollettino Scientifico della Facolta di Chimica Industriale di Bologna, vol. Date 1944-1947, 5, 48-51. CA 44: 19897, 1950.
Caine et al., Cancer 98(8), 1578-1586, 2003.
Brown, D.M., and George A.R. Kon, “Some Heterocyclic Analogues of Stilbenes,”J. Chem. Soc.:2147-2153, 1948.
Bundy, G.L., et al., “Synthesis of 2,4-Diaminopyrrolo[2,3-d]Pyrimidines Via Thermal Fischer Indolization. Pyrazole Formation with Ytterbium Triflate Catalysis,”J. Heterocyclic Chem. 37:1471-1477, Nov.-Dec. 2000.
Bundy, G.L., et al., “Synthesis of Novel 2,4-Diaminopyrrolo[2,3-d]Pyrimidines With Antioxidant, Neuroprotective, and Antiasthma Activity,”J. Med. Chem. 38:4161-4163, 1995.
Cabaj, J.E., et al., “Bromine-Mediated Addition of Nucleophiles to the Electron-Rich Pyrimidine Subunit of Tirilazad,”J. Org. Chem. 59:5090-5092, 1994.
Kowalewski, A., et al., “Unfused Hetrobicycles as Amplifiers of Phleomycin. IV 4,5′-Bipyrimidines with Dimethylamino and/or Dimethylaminoethylamino Substituents,”Aust. J. Chem. 34(12):2929-2933, 1981.
Ouf, A.A. Abou, et al., “Preparation of Some Methyl Pyrimidines Expected to be Antimetabolites,”Egypt J. Pharm. Sci. 14(2):180-195, 1973.
Font, D., et al., Development of an Efficient and Straightforward Methodology Toward the Synthesis of Molecularly Diverse 2,6-Disubstituted 3,4-Dihydropyrimidin-4(3H)-ones,Synthesis 13:1833-1842, Sep. 20, 2002.

Affiliated with

Also associated with

Rating

Small molecule PI 3-kinase inhibitors and methods of their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Small molecule PI 3-kinase inhibitors and methods of their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small molecule PI 3-kinase inhibitors and methods of their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3968905